Posted on December 30, 2015 by Sitemaster
A new study in JAMA Oncology has suggested that surgical orchiectomy may have lower risk for complications and side effects than medical castration with LHRH agonists (also known as GnRH agonists) like leuprolide acetate (Lupron) and others in treatment of men newly diagnosed with metastatic prostate cancer. This is a complex issue! … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: adverse effects, castration, medical, metastatic, orchiectomy, surgical | 11 Comments »
Posted on March 22, 2013 by Sitemaster
A new article on the Medscape Oncology web site (and again correlated with a media release sent out by the European Association for Urology [EAU] from their annual meeting in Milan, Italy) is headed “Prostate cancer vaccine shows promise.” However, the degree of that “promise” appears to be open to some question. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management | Tagged: castration, dexamethasone, multi-peptide, outcome, PSA, resistant, trial, vaccine | 7 Comments »
Posted on August 2, 2012 by Sitemaster
When women and their doctors talk about “hormone therapy” they are most commonly referring to the (now) highly controversial issue of whether hormonal supplements (estrogen and progesterone) should be used at and after menopause to prevent the symptoms of menopause and/or later risks related to heart disease and osteoporesis. … READ MORE …
Filed under: Management, Treatment | Tagged: androgen deprivation, castration, definition, hormone therapy, medical, surgical | 21 Comments »
Posted on November 4, 2010 by Sitemaster
Sometimes there is a piece of research published that provides truly astonishing data for members of the prostate cancer community. The following report is NOT one of these — unless you are a laboratory rat or can appreciate the potential implications for professional, long-distance cyclists. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: ADT, castration, rat | 4 Comments »
Posted on November 1, 2010 by Sitemaster
A recent article in the International Journal of Men’s Health argues that we need to be more honest with patients about the impact of “hormone therapy” in the treatment of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation, castration, emasculation, erectile function, language, masculinity | 14 Comments »
Posted on September 24, 2010 by Sitemaster
According to a Reuters report based on a recent media release from GTx, the investigational agent GTx-758 is able to induce temporary medical castration in healthy volunteers, making this agent yet another possible candidate for the hormonal management of progressive prostate cancer. … READ MORE …
Filed under: Drugs in development | Tagged: advanced, castration, GTx-758 | Leave a comment »
Posted on November 13, 2008 by Sitemaster
Today’s reports include items on:
- Perceptions of pain and discomfort in men undergoing DRE
- 10-year survival data of men with pT3 disease treated initially with a radical prostatectomy
- Orchiectomy, medical castration, and acceptable social costs
- Hemi-body radiation to treat pain in men with multiple bone metastases … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: castration, DRE, hemi-body radiation, orchiectomy, stage T3 disease | Leave a comment »
Posted on August 5, 2008 by Sitemaster
So after a few days becalmed in a world of minimal prostate cancer news … we have a fine controversy to revisit and some other interesting titbits to gnaw on … … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: cancer, castration, hormone, LUTS, metastasis, news, nomogram, outcomes, prostate, prostatectomy, radical, refractory, resistant, screening, survival, update | Leave a comment »
